FDA to Accelerate Development of Blood-Related Therapies for COVID-19
April 6, 2020
The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.
Gabrielle Ientile, Assistant Editor
University of Pittsburgh Announces Promising Vaccine Candidate
April 6, 2020
“We know exactly where to fight this new virus,” University of Pittsburgh School of Medicine said.
Coronavirus News Roundup: FDA Emergency Use Authorizations, Vaccine Candidate, and Virtual Blood Drives
April 3, 2020
Here's a roundup of the latest coronavirus-related news.
Coronavirus News Roundup: Inhaler Shortages, Updates on Potential Treatments
March 27, 2020
Here’s a roundup of the latest coronavirus-related news from this week.
AMA, APhA, ASHP Issue Joint Statement on Use of Medications to Treat COVID-19
March 26, 2020
In a joint statement, the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) have communicated concerns regarding the inappropriate ordering, prescribing, or dispensing of treatments for COVID-19.
COVID-19: The Multifaceted Search for Potential Treatments
March 25, 2020
Convalescent plasma, hydroxychloroquine, and remdesivir among the potential COVID-19 treatment pathways being pursued.
Protecting Children from COVID-19 Critical for Flattening the Curve
March 24, 2020
Pediatricians stress the importance of understanding the effects of COVID-19 on children.
Study Findings Support Scaling Up PrEP Use in the US to Fight HIV
March 23, 2020
Increases in PrEP coverage were associated with reductions in HIV infections, a new study found.
COVID-19: What Community Pharmacies Are Doing in the Hardest-Hit States
March 19, 2020
Perspectives from pharmacy associations in the states hardest hit with the COVID-19 outbreak.
Analysis Shows Potential Targets for Immune Responses to Novel Coronavirus
March 19, 2020
A study identified significant similarities between SARS-CoV and SARS-CoV-2.
